Developer docs
API playgroundTry for free, no card

Search company profiles

ICMR- Vector Control Research Centre

Full company profile

uuid005jt9t

Namestring
ICMR- Vector Control Research Centre
Legal namestring
ICMR-National Institute of Vector Control Research
Company typeenum
Private
Founded yearint
1975
Descriptiontext

ICMR-National Institute of Vector Control Research (NIVCR) is a permanent government research institute under the Indian Council of Medical Research (ICMR), Department of Health Research, Government of India. Established in July 1975 at Puducherry, the institute's mandate is to develop new methods, tools, and strategies for the control of vector-borne diseases (VBDs), including malaria, dengue, chikungunya, lymphatic filariasis, Japanese encephalitis, scrub typhus, Kyasanur Forest Disease, and leishmaniasis. It operates ten research divisions spanning vector biology and control, microbiology and molecular biology, biostatistics and VBD modelling, clinical epidemiology and chemotherapy, OMICS, innovation and product development, molecular epidemiology, one health, and climate change/GIS-based VBD stratification, supported by specialized facilities including a WHO-grade insectary, GLP-accredited laboratories, a microbial culture collection maintained since 1978, a 43,388-specimen mosquito museum, a genetic analyser, a CPCSEA-registered animal house, and an MMDP clinic for filarial lymphoedema patients. The institute also runs an M.Sc. Public Health Entomology programme and PhD affiliations with Pondicherry and Bharathiar universities.

The institute has generated a portfolio of indigenous products and IP, including four granted patents (notably macrofilaricidal compositions from Trachyspermum ammi and controlled-release insect growth regulators), bio-control agents (Bacillus thuringiensis var. israelensis, Pseudomonas fluorescens, Bacillus subtilis), the DEPA mosquito repellent, Wolbachia-infected Aedes aegypti release lines, indigenous Insecticide Impregnated Papers for vector resistance monitoring, and a long-lasting insecticidal net (MAGNet) in Phase III evaluation. NIVCR does not operate a commercial revenue model; it is funded by Government of India budgetary allocations through ICMR/DHR, and serves government health departments, the National Vector Borne Disease Control Programme (NVBDCP), state health services, WHO collaborating networks, and academic/research institutions through technical support, training, technology transfer, and capacity building rather than commercial sales. Its go-to-market is non-commercial: outputs are disseminated via peer-reviewed publications, training workshops, policy recommendations, and direct technical engagement with national disease control programmes.

Short descriptiontext

ICMR-NIVCR is a Government of India research institute under ICMR/DHR, established 1975 in Puducherry, developing vector control methods, diagnostics, bio-control agents, and training for malaria, dengue, filariasis, and other vector-borne diseases for state and national health programmes.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPuducherry, Puducherry, India
HQ citystring
Puducherry, Puducherry
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vector-borne disease research, medical entomology, vector control products, insecticide resistance monitoring, public health entomology training
Industry5 codes
1Vector-Borne Disease Surveillance & Control
CodeHLAJABAGPrimaryYes
2Tick-Borne & Vector-Borne Diseases
CodeHLAKAGALPrimaryNo
3Microbiology & Infectious Disease Diagnostics (Culture/ID/AST)
CodeHLAHAAACPrimaryNo
4Mosquito & Tick Control
CodeIMAIAHAIPrimaryNo
5Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza)
CodeHLAJAIADPrimaryNo
NAICS code2 codes
  • Medical Laboratories621511
  • Exterminating and Pest Control Services56171
SIC code2 codes
  • Services-Medical Laboratories8071
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Vector-Borne Disease Research and Control
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Government Research Funding
TypeLicensing Royalties
Description

Funded by Government of India through Indian Council of Medical Research (ICMR), Department of Health Research (DHR). Receives grants for intramural research, extramural projects, and serves as a permanent institute of ICMR.

vcrc.icmr.org.in
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

ICMR-NIVCR is a government research institute that conducts basic and applied research to develop newer methods, products, diagnostics, and strategies for the control of vector-borne diseases including malaria, dengue, chikungunya, lymphatic filariasis, Japanese encephalitis, scrub typhus, Kyasanur Forest Disease, and leishmaniasis. Its deliverables span bacterial bio-control agents, macrofilaricidal drug compositions, insect growth regulators, mosquito repellents, insecticide impregnated papers, Wolbachia-infected Aedes aegypti lines, rapid diagnostic assays, long-lasting insecticidal nets, and ovitraps, supported by GLP-accredited laboratories and a unique mosquito museum. It also delivers capacity building through the M.Sc. Public Health Entomology programme, PhD affiliations, training workshops, and clinical MMDP services for filarial lymphoedema patients.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Developed LYMFASIM model for estimating MDA duration for LF elimination, now used for WHO transmission assessment surveys
+3 more records
Product overview1 text field

ICMR-National Institute of Vector Control Research (NIVCR) is a government research institute under the Indian Council of Medical Research, established in 1975 in Puducherry. The institute operates as a research-focused organization rather than a commercial product company, developing vector control technologies, bio-control agents, diagnostic tools, and drug candidates primarily for vector-borne diseases including malaria, dengue, chikungunya, filariasis, Japanese encephalitis, scrub typhus, and leishmaniasis. The product portfolio includes bacterial bio-control agents (Bacillus thuringiensis var. israelensis, Pseudomonas fluorescens, Bacillus subtilis), drug formulations (macrofilaricidal compositions, DEC salt), vector control products (mosquito repellents, insect growth regulators like DPE-28, long-lasting insecticidal nets), diagnostic tools (rapid dengue tests, scrub typhus IgM ELISA), and innovative technologies (Wolbachia-infected mosquitoes, nanoparticle-based assays, insecticide impregnated papers). These products are developed through various research divisions and transferred to government programs and industry partners rather than sold as a unified commercial software or product platform.

Product and service22 records
1Bacterial Bio-Control Agents for Mosquito Larval Control
CategoryVector Control Product
Description

A portfolio of bacterial bio-control agents used against mosquito larvae in vector-borne disease control programmes, including Bacillus thuringiensis var. israelensis, Pseudomonas fluorescens, Bacillus subtilis, and Bacillus thuringiensis.

2Novel Macrofilaricidal Composition
CategoryDrug Development
Description

Macrofilaricidal composition developed by Nisha Mathew, Kalyanasundaram M and Balaraman K for treatment of lymphatic filariasis, granted Indian Patent No. 280638 (2017).

3Trachyspermum ammi-based Macrofilaricidal Agent
CategoryDrug Development
Description

Macrofilaricidal activity of monoterpene derivatives from Trachyspermum ammi (Ajwain) fruit extract against filariasis, granted Indian Patent No. 274393 (2016).

4DPE-28 Controlled Release Insect Growth Regulator Formulation
CategoryVector Control Product
Description

Controlled release formulation of the insect growth regulator DPE-28 for mosquito larval control, granted Indian Patent No. 191820 (2005).

5Cyclosporin-A Production Technology from Tolypocladium species
CategoryBiotechnology
Description

Multi-jurisdictional patented process for the preparation of Cyclosporin-A from Tolypocladium species (US Patent 5,656,459; Brazilian BR9601017; European EP-96-356060/36; Indian 183940; DE69521193T; Canadian CA-2142240 C).

6DEPA Mosquito Repellent Formulation
CategoryVector Control Product
Description

Mosquito repellent formulation developed for personal protection against mosquito bites.

7Essential Oil Mosquito Repellent Combinations
CategoryVector Control Product
Description

Plant-derived essential oil combinations developed as mosquito repellents for personal protection.

8E-57 Mosquito Oviposition Attractant
CategoryVector Surveillance Product
Description

Synthetic mosquito oviposition attractant for vector surveillance and control applications.

9Synthetic Pyrethroid Esters (P-29 and P-38)
CategoryVector Control Chemical
Description

Synthetic pyrethroid esters developed for adulticidal and larvicidal activity against mosquitoes.

10Insecticide Impregnated Papers (IIPs)
CategoryDiagnostic/Testing Product
Description

Indigenous insecticide impregnated papers prepared and supplied to NVBDCP for monitoring susceptibility and resistance in vector mosquitoes across India.

11Wolbachia-infected Aedes aegypti Release Lines
CategoryBiological Control Agent
Description

Wolbachia-carrying Aedes aegypti mosquitoes (wMel and wAlbB infected lines) for dengue and chikungunya control through cytoplasmic incompatibility, including the A226V mutation discovery in the CHIKV envelope gene.

12MAGNet Long-Lasting Insecticidal Net
CategoryVector Control Product
Description

Alpha-cypermethrin long-lasting insecticidal net for malaria vector control, currently undergoing Phase III evaluation.

13Ovillanta Ovitrap
CategoryVector Surveillance/Control Product
Description

Cost-effective ovitrap design for dengue and chikungunya vector surveillance and control.

14Nanoparticle-based Rapid Dengue Diagnostic Assay
CategoryDiagnostic Product
Description

Nanoparticle-based rapid diagnostic assay for detecting dengue virus in mosquitoes, developed at the Madurai field station.

15Scrub Typhus IgM ELISA and Antigen Detection Test
CategoryDiagnostic Product
Description

IgM ELISA and antigen detection tests developed for diagnosis of scrub typhus in humans, supporting India's first national guidelines on scrub typhus diagnostics and management.

16DEC Salt Formulation
CategoryDrug Development
Description

Diethylcarbamazine (DEC) medicated salt formulation for mass chemotherapy of lymphatic filariasis, with accompanying HPLC analytical method.

17Lymphatic Filariasis Rapid Diagnostic Tools
CategoryDiagnostic Product
Description

Rapid antigen testing tools developed for filariasis detection and surveillance in support of national LF elimination efforts.

18Silver Nanoparticles and Nanofibre Encapsulation for Mosquito Control
CategoryNanotechnology Product
Description

Biosynthesized silver nanoparticles from plants for mosquito vector control, and nanofibre encapsulation technology for sustained production of mosquito larvicides using Pseudomonas fluorescens.

19M.Sc. Public Health Entomology and Ph.D. Programmes
CategoryEducation and Training
Description

Academic programmes in Public Health Entomology (M.Sc. PHE) and affiliated Ph.D. programmes through Pondicherry University and Bharathiar University, building national capacity in medical entomology and vector-borne disease research.

20Capacity Building Training Workshops on Vectors and VBDs
CategoryTraining and Capacity Building
Description

Training workshop series on vectors and vector-borne diseases delivered to state government health personnel, medical college staff, and international researchers, supporting nationwide capacity building.

21Morbidity Management and Disability Prevention (MMDP) Clinical Services
CategoryClinical Services
Description

Clinical services for filarial lymphoedema patients including pneumatic decompression therapy, manual lymphatic drainage, and yoga therapy delivered at the NIVCR MMDP clinic.

22Mosquito Attractant Blends
CategoryVector Surveillance Product
Description

Small molecule mosquito attractant blends developed for vector surveillance applications.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

WHO designated NIVCR as a Collaborating Centre for Research and Training in Lymphatic Filariasis and Integrated Vector Management on 15th May 1985. This designation enables international collaboration, research support, and training programmes for vector-borne disease control.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NIVCR is one of the permanent institutes of ICMR, Department of Health Research, Government of India. Receives institutional funding and coordinates research through ICMR network.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Under DHR along with ICMR, NIVCR conducts research and receives funding for disease research initiatives including Model Rural Health Research Unit.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic affiliation for PhD programmes. PhD scholars from NIVCR affiliated to Pondicherry University.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partnership for research and education in vector-borne disease research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NIVCR provides insecticide impregnated papers and technical support to NVBDCP for national insecticide resistance monitoring programme.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration for development of LYMFASIM model for lymphatic filariasis transmission modelling.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Received Wolbachia carrying Aedes aegypti eggs from Monash University for Wolbachia-based dengue control research.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Collaboration in GLP facility development and public health pesticide evaluation research.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight1 record

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Institut Pasteur network member focused on vector-borne diseases (malaria, plague, arboviruses) with laboratory, field, and reference centre functions. Comparable research infrastructure including insectaries, diagnostic labs, and WHO-grade reference functions, though operating in Madagascar rather than India.

TypeDirect peer
Description

Tanzanian research institute with a strong vector control and malaria research portfolio, including field stations and WHO collaborating centre functions. Operates in a different geography but on closely comparable topics — mosquito biology, insecticide resistance, and vector-borne disease surveillance — making it a strong methodological peer.

TypeDirect peer
Description

Another permanent institute of ICMR focused on malaria research and control, with shared GLP testing collaboration on public health pesticides. Operates under the same parent (ICMR/DHR) and serves overlapping NVBDCP mandates, making it the most directly comparable peer for institutional structure, funding model, and research scope.

TypeBroad incumbent
Description

Historic UK-based institution focused on tropical disease research and vector control, with WHO collaborating centre functions and long-standing partnerships with NIVCR through shared filariasis programmes. Comparable in international training and translational research focus, but operates as an academic rather than government entity.

TypeDirect peer
Description

Global non-profit deploying Wolbachia-carrying Aedes aegypti mosquitoes for dengue and chikungunya control — exactly the technology NIVCR has imported from Monash University. Directly competing on Wolbachia scale-up and field deployment, though World Mosquito Program operates at far greater geographic scale and is the field-deployment leader.

6National Institute of Malaria, Parasitology and Entomology (NIMPE), Vietnam
TypeRegional player
Description

Vietnamese government research institute focused on malaria, parasitology, and medical entomology — directly comparable in mission and institutional structure to NIVCR. Both serve as national reference centres for vector control with WHO collaborating functions, but operate in different geographies.

TypeBroad incumbent
Description

US federal agency with the Division of Vector-Borne Diseases conducting arboviral disease, malaria, and Lyme disease research — overlapping strongly with NIVCR's portfolio on surveillance, diagnostics, and vector control. Operates at vastly greater scale and budget, but shares the government research institute model with WHO collaborating centre status.

8National Institute of Epidemiology (NIE), Chennai
TypeDirect peer
Description

Sister ICMR institute in Chennai focused on epidemiological research, training, and field investigations for communicable diseases. Shares the same government research institute structure, ICMR oversight, and public health mandate, with overlapping interests in disease surveillance and outbreak investigation.

TypeBroad incumbent
Description

Direct parent organization overseeing NIVCR and 26 other permanent research institutes. Provides funding, governance, and policy direction for vector-borne disease research in India — and therefore the most institutionally comparable entity, though operating as an apex coordinating body rather than a research lab.

TypeBroad incumbent
Description

National medical research institute in Kenya with established programmes on malaria, leishmaniasis, and other vector-borne diseases. Comparable institutional model — government-funded, multi-disease research portfolio, field stations, and WHO collaborating centre status — but operates at broader geographic scale across East Africa.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ICMR- Vector Control Research Centre

Vector-Borne Disease Research and Controlvcrc.icmr.org.in

ICMR-NIVCR is a Government of India research institute under ICMR/DHR, established 1975 in Puducherry, developing vector control methods, diagnostics, bio-control agents, and training for malaria, dengue, filariasis, and other vector-borne diseases for state and national health programmes.

What ICMR- Vector Control Research Centre does

ICMR-National Institute of Vector Control Research (NIVCR) is a permanent government research institute under the Indian Council of Medical Research (ICMR), Department of Health Research, Government of India. Established in July 1975 at Puducherry, the institute's mandate is to develop new methods, tools, and strategies for the control of vector-borne diseases (VBDs), including malaria, dengue, chikungunya, lymphatic filariasis, Japanese encephalitis, scrub typhus, Kyasanur Forest Disease, and leishmaniasis. It operates ten research divisions spanning vector biology and control, microbiology and molecular biology, biostatistics and VBD modelling, clinical epidemiology and chemotherapy, OMICS, innovation and product development, molecular epidemiology, one health, and climate change/GIS-based VBD stratification, supported by specialized facilities including a WHO-grade insectary, GLP-accredited laboratories, a microbial culture collection maintained since 1978, a 43,388-specimen mosquito museum, a genetic analyser, a CPCSEA-registered animal house, and an MMDP clinic for filarial lymphoedema patients. The institute also runs an M.Sc. Public Health Entomology programme and PhD affiliations with Pondicherry and Bharathiar universities.

The institute has generated a portfolio of indigenous products and IP, including four granted patents (notably macrofilaricidal compositions from Trachyspermum ammi and controlled-release insect growth regulators), bio-control agents (Bacillus thuringiensis var. israelensis, Pseudomonas fluorescens, Bacillus subtilis), the DEPA mosquito repellent, Wolbachia-infected Aedes aegypti release lines, indigenous Insecticide Impregnated Papers for vector resistance monitoring, and a long-lasting insecticidal net (MAGNet) in Phase III evaluation. NIVCR does not operate a commercial revenue model; it is funded by Government of India budgetary allocations through ICMR/DHR, and serves government health departments, the National Vector Borne Disease Control Programme (NVBDCP), state health services, WHO collaborating networks, and academic/research institutions through technical support, training, technology transfer, and capacity building rather than commercial sales. Its go-to-market is non-commercial: outputs are disseminated via peer-reviewed publications, training workshops, policy recommendations, and direct technical engagement with national disease control programmes.

ICMR- Vector Control Research Centre firmographics

Firmographics
Name
ICMR- Vector Control Research Centre
Legal name
ICMR-National Institute of Vector Control Research
Website
https://vcrc.icmr.org.in
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
11–50 employees
Short description
ICMR-NIVCR is a Government of India research institute under ICMR/DHR, established 1975 in Puducherry, developing vector control methods, diagnostics, bio-control agents, and training for malaria, dengue, filariasis, and other vector-borne diseases for state and national health programmes.
Ownership category
akta.pro rank

ICMR- Vector Control Research Centre industry classification

Industry
Product category
Vector-Borne Disease Research and Control
NAICS
Medical Laboratories (621511), Exterminating and Pest Control Services (56171)
SIC
Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Vector-Borne Disease Surveillance & Control (HLAJABAG)
akta.pro secondary industries
Tick-Borne & Vector-Borne Diseases (HLAKAGAL), Microbiology & Infectious Disease Diagnostics (Culture/ID/AST) (HLAHAAAC), Mosquito & Tick Control (IMAIAHAI), Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD)

Keywords

  • Vector-borne disease research
  • Medical entomology
  • Vector control products
  • Insecticide resistance monitoring
  • Public health entomology training

Where ICMR- Vector Control Research Centre is headquartered

Location

Headquarters

HQ city
Puducherry, Puducherry
HQ country
India
HQ region
Asia

Offices4 records

Markets served

ICMR- Vector Control Research Centre business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

  1. Government Research Funding: Funded by Government of India through Indian Council of Medical Research (ICMR), Department of Health Research (DHR). Receives grants for intramural research, extramural projects, and serves as a permanent institute of ICMR.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

ICMR- Vector Control Research Centre product offering

Product offering

Core offering

ICMR-NIVCR is a government research institute that conducts basic and applied research to develop newer methods, products, diagnostics, and strategies for the control of vector-borne diseases including malaria, dengue, chikungunya, lymphatic filariasis, Japanese encephalitis, scrub typhus, Kyasanur Forest Disease, and leishmaniasis. Its deliverables span bacterial bio-control agents, macrofilaricidal drug compositions, insect growth regulators, mosquito repellents, insecticide impregnated papers, Wolbachia-infected Aedes aegypti lines, rapid diagnostic assays, long-lasting insecticidal nets, and ovitraps, supported by GLP-accredited laboratories and a unique mosquito museum. It also delivers capacity building through the M.Sc. Public Health Entomology programme, PhD affiliations, training workshops, and clinical MMDP services for filarial lymphoedema patients.

Product overview

ICMR-National Institute of Vector Control Research (NIVCR) is a government research institute under the Indian Council of Medical Research, established in 1975 in Puducherry. The institute operates as a research-focused organization rather than a commercial product company, developing vector control technologies, bio-control agents, diagnostic tools, and drug candidates primarily for vector-borne diseases including malaria, dengue, chikungunya, filariasis, Japanese encephalitis, scrub typhus, and leishmaniasis. The product portfolio includes bacterial bio-control agents (Bacillus thuringiensis var. israelensis, Pseudomonas fluorescens, Bacillus subtilis), drug formulations (macrofilaricidal compositions, DEC salt), vector control products (mosquito repellents, insect growth regulators like DPE-28, long-lasting insecticidal nets), diagnostic tools (rapid dengue tests, scrub typhus IgM ELISA), and innovative technologies (Wolbachia-infected mosquitoes, nanoparticle-based assays, insecticide impregnated papers). These products are developed through various research divisions and transferred to government programs and industry partners rather than sold as a unified commercial software or product platform.

Differentiator

Problem solved

Functional benefit

Products and services

  • Bacterial Bio-Control Agents for Mosquito Larval Control A portfolio of bacterial bio-control agents used against mosquito larvae in vector-borne disease control programmes, including Bacillus thuringiensis var. israelensis, Pseudomonas fluorescens, Bacillus subtilis, and Bacillus thuringiensis.
  • Novel Macrofilaricidal Composition Macrofilaricidal composition developed by Nisha Mathew, Kalyanasundaram M and Balaraman K for treatment of lymphatic filariasis, granted Indian Patent No. 280638 (2017).
  • Trachyspermum ammi-based Macrofilaricidal Agent Macrofilaricidal activity of monoterpene derivatives from Trachyspermum ammi (Ajwain) fruit extract against filariasis, granted Indian Patent No. 274393 (2016).
  • DPE-28 Controlled Release Insect Growth Regulator Formulation Controlled release formulation of the insect growth regulator DPE-28 for mosquito larval control, granted Indian Patent No. 191820 (2005).
  • Cyclosporin-A Production Technology from Tolypocladium species Multi-jurisdictional patented process for the preparation of Cyclosporin-A from Tolypocladium species (US Patent 5,656,459; Brazilian BR9601017; European EP-96-356060/36; Indian 183940; DE69521193T; Canadian CA-2142240 C).
  • DEPA Mosquito Repellent Formulation Mosquito repellent formulation developed for personal protection against mosquito bites.
  • Essential Oil Mosquito Repellent Combinations Plant-derived essential oil combinations developed as mosquito repellents for personal protection.
  • E-57 Mosquito Oviposition Attractant Synthetic mosquito oviposition attractant for vector surveillance and control applications.
  • Synthetic Pyrethroid Esters (P-29 and P-38) Synthetic pyrethroid esters developed for adulticidal and larvicidal activity against mosquitoes.
  • Insecticide Impregnated Papers (IIPs) Indigenous insecticide impregnated papers prepared and supplied to NVBDCP for monitoring susceptibility and resistance in vector mosquitoes across India.
  • Wolbachia-infected Aedes aegypti Release Lines Wolbachia-carrying Aedes aegypti mosquitoes (wMel and wAlbB infected lines) for dengue and chikungunya control through cytoplasmic incompatibility, including the A226V mutation discovery in the CHIKV envelope gene.
  • MAGNet Long-Lasting Insecticidal Net Alpha-cypermethrin long-lasting insecticidal net for malaria vector control, currently undergoing Phase III evaluation.
  • Ovillanta Ovitrap Cost-effective ovitrap design for dengue and chikungunya vector surveillance and control.
  • Nanoparticle-based Rapid Dengue Diagnostic Assay Nanoparticle-based rapid diagnostic assay for detecting dengue virus in mosquitoes, developed at the Madurai field station.
  • Scrub Typhus IgM ELISA and Antigen Detection Test IgM ELISA and antigen detection tests developed for diagnosis of scrub typhus in humans, supporting India's first national guidelines on scrub typhus diagnostics and management.
  • DEC Salt Formulation Diethylcarbamazine (DEC) medicated salt formulation for mass chemotherapy of lymphatic filariasis, with accompanying HPLC analytical method.
  • Lymphatic Filariasis Rapid Diagnostic Tools Rapid antigen testing tools developed for filariasis detection and surveillance in support of national LF elimination efforts.
  • Silver Nanoparticles and Nanofibre Encapsulation for Mosquito Control Biosynthesized silver nanoparticles from plants for mosquito vector control, and nanofibre encapsulation technology for sustained production of mosquito larvicides using Pseudomonas fluorescens.
  • M.Sc. Public Health Entomology and Ph.D. Programmes Academic programmes in Public Health Entomology (M.Sc. PHE) and affiliated Ph.D. programmes through Pondicherry University and Bharathiar University, building national capacity in medical entomology and vector-borne disease research.
  • Capacity Building Training Workshops on Vectors and VBDs Training workshop series on vectors and vector-borne diseases delivered to state government health personnel, medical college staff, and international researchers, supporting nationwide capacity building.
  • Morbidity Management and Disability Prevention (MMDP) Clinical Services Clinical services for filarial lymphoedema patients including pneumatic decompression therapy, manual lymphatic drainage, and yoga therapy delivered at the NIVCR MMDP clinic.
  • Mosquito Attractant Blends Small molecule mosquito attractant blends developed for vector surveillance applications.

Quantifiable outcome

  • Developed LYMFASIM model for estimating MDA duration for LF elimination, now used for WHO transmission assessment surveys
  • +3 more outcomes

Companies that use ICMR- Vector Control Research Centre

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

ICMR- Vector Control Research Centre technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

ICMR- Vector Control Research Centre partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core and minor.

  • World Health Organization (WHO)coreStrategic or Co-development PartnerWHO designated NIVCR as a Collaborating Centre for Research and Training in Lymphatic Filariasis and Integrated Vector Management on 15th May 1985. This designation enables international collaboration, research support, and training programmes for vector-borne disease control.
  • Indian Council of Medical Research (ICMR)coreStrategic or Co-development PartnerNIVCR is one of the permanent institutes of ICMR, Department of Health Research, Government of India. Receives institutional funding and coordinates research through ICMR network.
  • Department of Health Research (DHR), Government of IndiacoreStrategic or Co-development PartnerUnder DHR along with ICMR, NIVCR conducts research and receives funding for disease research initiatives including Model Rural Health Research Unit.
  • Pondicherry UniversityminorStrategic or Co-development PartnerAcademic affiliation for PhD programmes. PhD scholars from NIVCR affiliated to Pondicherry University.
  • Bharathiar UniversityminorStrategic or Co-development PartnerAcademic partnership for research and education in vector-borne disease research.
  • National Vector Borne Disease Control Programme (NVBDCP)coreStrategic or Co-development PartnerNIVCR provides insecticide impregnated papers and technical support to NVBDCP for national insecticide resistance monitoring programme.
  • Erasmus University, RotterdamminorStrategic or Co-development PartnerCollaboration for development of LYMFASIM model for lymphatic filariasis transmission modelling.
  • Monash University, AustraliaminorStrategic or Co-development PartnerReceived Wolbachia carrying Aedes aegypti eggs from Monash University for Wolbachia-based dengue control research.
  • ICMR National Institute of Malaria ResearchminorStrategic or Co-development PartnerCollaboration in GLP facility development and public health pesticide evaluation research.

Scale indicators10 records

Recent moves6 records

Expansion highlights1 record

ICMR- Vector Control Research Centre competitors and assessment

Company assessment

Direct peers

  • Institut Pasteur de Madagascar: Institut Pasteur network member focused on vector-borne diseases (malaria, plague, arboviruses) with laboratory, field, and reference centre functions. Comparable research infrastructure including insectaries, diagnostic labs, and WHO-grade reference functions, though operating in Madagascar rather than India.
  • Ifakara Health Institute: Tanzanian research institute with a strong vector control and malaria research portfolio, including field stations and WHO collaborating centre functions. Operates in a different geography but on closely comparable topics — mosquito biology, insecticide resistance, and vector-borne disease surveillance — making it a strong methodological peer.
  • ICMR-National Institute of Malaria Research (NIMR): Another permanent institute of ICMR focused on malaria research and control, with shared GLP testing collaboration on public health pesticides. Operates under the same parent (ICMR/DHR) and serves overlapping NVBDCP mandates, making it the most directly comparable peer for institutional structure, funding model, and research scope.
  • World Mosquito Program: Global non-profit deploying Wolbachia-carrying Aedes aegypti mosquitoes for dengue and chikungunya control — exactly the technology NIVCR has imported from Monash University. Directly competing on Wolbachia scale-up and field deployment, though World Mosquito Program operates at far greater geographic scale and is the field-deployment leader.
  • National Institute of Epidemiology (NIE), Chennai: Sister ICMR institute in Chennai focused on epidemiological research, training, and field investigations for communicable diseases. Shares the same government research institute structure, ICMR oversight, and public health mandate, with overlapping interests in disease surveillance and outbreak investigation.

Broad incumbents

  • Liverpool School of Tropical Medicine: Historic UK-based institution focused on tropical disease research and vector control, with WHO collaborating centre functions and long-standing partnerships with NIVCR through shared filariasis programmes. Comparable in international training and translational research focus, but operates as an academic rather than government entity.
  • Centers for Disease Control and Prevention (CDC): US federal agency with the Division of Vector-Borne Diseases conducting arboviral disease, malaria, and Lyme disease research — overlapping strongly with NIVCR's portfolio on surveillance, diagnostics, and vector control. Operates at vastly greater scale and budget, but shares the government research institute model with WHO collaborating centre status.
  • Indian Council of Medical Research (ICMR) Headquarters: Direct parent organization overseeing NIVCR and 26 other permanent research institutes. Provides funding, governance, and policy direction for vector-borne disease research in India — and therefore the most institutionally comparable entity, though operating as an apex coordinating body rather than a research lab.
  • Kenya Medical Research Institute (KEMRI): National medical research institute in Kenya with established programmes on malaria, leishmaniasis, and other vector-borne diseases. Comparable institutional model — government-funded, multi-disease research portfolio, field stations, and WHO collaborating centre status — but operates at broader geographic scale across East Africa.

Regional players

  • National Institute of Malaria, Parasitology and Entomology (NIMPE), Vietnam: Vietnamese government research institute focused on malaria, parasitology, and medical entomology — directly comparable in mission and institutional structure to NIVCR. Both serve as national reference centres for vector control with WHO collaborating functions, but operate in different geographies.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

ICMR- Vector Control Research Centre social profiles

Digital presence

ICMR- Vector Control Research Centre compliance and trust

Trust signal

Compliance2 records

ICMR- Vector Control Research Centre financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ICMR- Vector Control Research Centre leadership team

Management profile

Number of profiles

Profiles12 records

ICMR- Vector Control Research Centre subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

ICMR- Vector Control Research Centre funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ICMR- Vector Control Research Centre M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ICMR- Vector Control Research Centre

What does ICMR- Vector Control Research Centre do?

ICMR-NIVCR is a government research institute that conducts basic and applied research to develop newer methods, products, diagnostics, and strategies for the control of vector-borne diseases including malaria, dengue, chikungunya, lymphatic filariasis, Japanese encephalitis, scrub typhus, Kyasanur Forest Disease, and leishmaniasis. Its deliverables span bacterial bio-control agents, macrofilaricidal drug compositions, insect growth regulators, mosquito repellents, insecticide impregnated papers, Wolbachia-infected Aedes aegypti lines, rapid diagnostic assays, long-lasting insecticidal nets, and ovitraps, supported by GLP-accredited laboratories and a unique mosquito museum. It also delivers capacity building through the M.Sc. Public Health Entomology programme, PhD affiliations, training workshops, and clinical MMDP services for filarial lymphoedema patients.

Is ICMR- Vector Control Research Centre a public or private company?

ICMR- Vector Control Research Centre is a private company. It is classified as state government owned and is currently operating.

When was ICMR- Vector Control Research Centre founded?

ICMR- Vector Control Research Centre was founded in 1975. It employs 11 to 50 people.

Where is ICMR- Vector Control Research Centre based?

ICMR- Vector Control Research Centre is headquartered in Puducherry, Puducherry, India, in the Asia region.

How does ICMR- Vector Control Research Centre make money?

One revenue line is on record: government Research Funding.

Who are ICMR- Vector Control Research Centre's main competitors?

Direct peers on record are Institut Pasteur de Madagascar, Ifakara Health Institute, ICMR-National Institute of Malaria Research (NIMR), World Mosquito Program and National Institute of Epidemiology (NIE), Chennai. Broad incumbents are Liverpool School of Tropical Medicine, Centers for Disease Control and Prevention (CDC), Indian Council of Medical Research (ICMR) Headquarters and Kenya Medical Research Institute (KEMRI). National Institute of Malaria, Parasitology and Entomology (NIMPE), Vietnam is listed as a regional player.

Does ICMR- Vector Control Research Centre have an API?

No public API is recorded for ICMR- Vector Control Research Centre.

What industry is ICMR- Vector Control Research Centre in?

ICMR- Vector Control Research Centre's product category is Vector-Borne Disease Research and Control. Its primary akta.pro industry code is HLAJABAG, Vector-Borne Disease Surveillance & Control, with a secondary code of HLAKAGAL, Tick-Borne & Vector-Borne Diseases. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales